These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7382423)

  • 1. Aspirin treatment and platelet function in Kawasaki disease.
    Yokoyama T; Kato H; Ichinose E
    Kurume Med J; 1980; 27(1):57-61. PubMed ID: 7382423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the platelet mucocutaneous lymph node syndrome (MCLS)--platelet function--].
    Mukaiyama H
    Rinsho Ketsueki; 1982 Apr; 23(4):449-58. PubMed ID: 6215508
    [No Abstract]   [Full Text] [Related]  

  • 3. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent.
    Yamada K; Fukumoto T; Shinkai A; Shirahata A; Meguro T
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):791-802. PubMed ID: 716791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kawasaki mucocutaneous lymph node syndrome. 3 cases].
    Estavoyer JM; Boichard D; Folschweiller B; Baufle GH; Debrand J; Perat R
    Nouv Presse Med; 1979 Sep; 8(36):2908. PubMed ID: 493102
    [No Abstract]   [Full Text] [Related]  

  • 5. Kawasaki disease and aspirin.
    Denning DW
    Lancet; 1983 Sep; 2(8350):621. PubMed ID: 6136764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of blood neuraminidase activities and free sialic acid, with special reference to the fluctuations in Kawasaki disease].
    Yamada K; Meguro T; Miyaji Y; Mori N; Inagaki M; Tomita K; Taki M; Miura T; Saito N
    Rinsho Byori; 1983 Mar; Suppl 54():200-2. PubMed ID: 6887578
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the effect of long-term use of low dose aspirin in Kawasaki disease.
    Hamasaki Y; Ichimaru T; Tasaki H; Miyazaki S
    Acta Paediatr Jpn; 1988 Feb; 30(1):63-7. PubMed ID: 3148261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention and treatment of coronary lesions in Kawasaki disease. Treatment with anti-platelet agents and aspirin: optimum dosages and their evaluation].
    Shirahata A; Nakamura T; Asakura A
    Nihon Rinsho; 1983 Sep; 41(9):2103-10. PubMed ID: 6663747
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mucocutaneous lymph node syndrome, Kawasaki disease. A review and report of 3 cases].
    Rasmussen NH; Pedersen IL; Thelle T; Grymer LF; Christensen MF
    Ugeskr Laeger; 1980 Sep; 142(38):2472-5. PubMed ID: 7445146
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mucocutaneous lymph node syndrome or Kawasaki disease].
    Zulaíca D; Ruíz M; Alba A; Higes A; Damiano A
    Rev Clin Esp; 1981 Nov; 163(4):217-20. PubMed ID: 7038786
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease.
    Yahata T; Suzuki C; Yoshioka A; Hamaoka A; Ikeda K
    Circ J; 2014; 78(1):188-93. PubMed ID: 24152721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of current therapy of Kawasaki disease on eicosanoid metabolism.
    Fulton DR; Meissner C; Peterson MB
    Am J Cardiol; 1988 Jun; 61(15):1323-7. PubMed ID: 2454025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki disease. Kawasaki disease?
    Moss KW
    Alaska Med; 2000; 42(2):30-6. PubMed ID: 10916855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets in Kawasaki patients: two different populations with different mitochondrial functions.
    Pietraforte D; Gambardella L; Marchesi A; Tarissi de Jacobis I; Villani A; Del Principe D; Malorni W; Straface E
    Int J Cardiol; 2014 Mar; 172(2):526-8. PubMed ID: 24491862
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of antiplatelet therapy for Kawasaki disease: a systematic review.
    Tanoshima R; Hashimoto R; Suzuki T; Ishiguro A; Kobayashi T
    Eur J Pediatr; 2019 Jun; 178(6):947-955. PubMed ID: 30923908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete Kawasaki disease: a pediatric diagnostic conflict.
    Celik U; Alhan E; Arabaci F
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):343-4. PubMed ID: 17785242
    [No Abstract]   [Full Text] [Related]  

  • 17. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
    Fritz ME; Giambonini S; Jenni R; D'Apuzzo V
    Schweiz Med Wochenschr; 1981 Apr; 111(16):566-71. PubMed ID: 7233135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular involvement in Kawasaki disease.
    Narayanan SN; Ahamed MZ; Safia M
    Indian Pediatr; 2005 Sep; 42(9):918-22. PubMed ID: 16208052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin therapy in Kawasaki syndrome.
    Koren G
    J Pediatr; 1985 May; 106(5):859-60. PubMed ID: 3998933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mucocutaneous lymph node syndrome (Kawasaki disease) in adults].
    Horstmann E; Daweke H
    MMW Munch Med Wochenschr; 1982 Oct; 124(42):909-10. PubMed ID: 6819459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.